Target intelligence / Profile preview

Thiamine transporter 1 (SLC19A2), Thiamine transporter 2 (SLC19A3) (SLC19A2, SLC19A3)

Target
SLC19A2, SLC19A3
Molecular classification
Transporter, Solute carrier (SLC) family, Membrane protein
01

Overview

The main pyridoxine transporters in humans are Thiamine transporter 1 (SLC19A2) and Thiamine transporter 2 (SLC19A3), members of the solute carrier (SLC) family responsible for the high-affinity uptake of both thiamine (vitamin B1) and pyridoxine (vitamin B6)[2][3][4]. These transporters are expressed in the intestinal epithelium and other tissues, enabling absorption of non-phosphorylated B6 vitamers under physiologically acidic conditions typical of the intestinal microenvironment[3]. Their substrate specificity is determined by a unique set of amino acid residues in the transmembrane domains, with human SLC19A3 distinct in transporting pyridoxine compared to rodent orthologs[4]. They are implicated in competitive drug-nutrient interactions and are potential biomarkers or therapeutic targets, especially where transporter function is genetically impaired[2][3]. The designation "Pyridoxine transporter" is functionally descriptive but not a canonical protein name; for structured data, SLC19A2 and SLC19A3 should be used[2][3][4].

Other names
Thiamine transporter 1Thiamine transporter 2Solute carrier family 19 member 2Solute carrier family 19 member 3THTR-1THTR-2Vitamin B1 transporter
02

Mechanism of action

Competitive substrate inhibition (thiamine and pyridoxine compete for transport); Drug interaction via transporter occupancy or competition

03

Biological functions

Vitamin and micronutrient uptake (thiamine and pyridoxine)Intestinal absorption of pyridoxine and thiamineDrug uptake and drug-nutrient interactions
04

Disease associations

Vitamin B1/B6 deficiency syndromesMetabolic disorders impacting micronutrient availabilityPotential involvement in neurological disease via disturbed B-vitamin uptakeRare inherited transporter deficiency syndromes (e.g., Thiamine metabolism dysfunction syndrome)
05

Safety considerations

Drug-nutrient competition (risk of vitamin deficiency with transporter-inhibiting drugs such as fedratinib)Genetic transporter deficiencies (risk of severe metabolic and neurological symptoms)Saturable transporter kinetics with possible toxicity or deficiency
06

Interacting drugs

Metformin

6 more in the full profile.

07

Biomarkers

SLC19A2/SLC19A3 genetic variants (for patient selection in deficiency syndromes and drug response)Plasma pyridoxine and thiamine concentrations

Beyond the preview

Go deeper on Thiamine transporter 1 (SLC19A2), Thiamine transporter 2 (SLC19A3) (SLC19A2, SLC19A3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thiamine transporter 1 (SLC19A2), Thiamine transporter 2 (SLC19A3) (SLC19A2, SLC19A3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call